Gene · 6335
Papers3,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Electrophysiological Characterization of the Venom and Toxins from the Scorpion Tityus championi Targeting Voltage-Gated Sodium Channels and Molecular Modeling of Tch3, a Toxin with Therapeutic Potential for Pain Relief. | Biomolecules | 2026 | 42072673 | PubTator, text mining | PubMed |
| Dorsal Root Ganglion Stimulation for the Treatment of Burning Feet Syndrome Related to Erythromelalgia. | Pain Med Case Rep | 2026 | 42066262 | PubTator, text mining | PubMed |
| Voltage-gated sodium channels in pain: Which channels, which blockers, and where NaV1.7 fits. | Prog Biophys Mol Biol | 2026 | 42055169 | PubTator, text mining | PubMed |
| BikeZ-ETH - A Mass-Cycling Trajectory Dataset from a Controlled Experiment. | Sci Data | 2026 | 42026102 | PubTator, text mining | PubMed |
| Self-limited neonatal epilepsy with 2q24.3 duplications: Case series and literature review. | Epileptic Disord | 2026 | 42017391 | PubTator, text mining | PubMed |
| Mapping the Extended Pain Pathway: Human Genetic and Multi-Omic Strategies for Next-Generation Analgesics. | Int J Mol Sci | 2026 | 41977224 | PubTator, text mining | PubMed |
| Combinatorial logic of Nav channels in nociceptor excitability: Different degrees of synergy define distinct neuronal groups. | bioRxiv | 2026 | 41959114 | PubTator, text mining | PubMed |
| Study of enhancing analgesic potential of μ-conotoxins from the computational and pharmacological insights. | Mol Divers | 2026 | 41934563 | PubTator, text mining | PubMed |
| Pain Modulation and Central Sensitization in Painful Diabetic Peripheral Neuropathy: Updated Narrative Review and Future Directions. | J Diabetes | 2026 | 41934114 | PubTator, text mining | PubMed |
| Modulation of human dorsal root ganglion neuron excitability by Nav1.7 inhibition. | bioRxiv | 2026 | 41929119 | PubTator, text mining | PubMed |
| Impact of different doses of remifentanil on postoperative pain and hyperalgesia: a prospective randomized controlled study and genotypic analysis. | J Clin Anesth | 2026 | 41916108 | PubTator, text mining | PubMed |
| Design, Synthesis, and Structure-Activity Relationship Study of μ-Conotoxin KIIIA toward NaV1.4. | J Med Chem | 2026 | 41913656 | PubTator, text mining | PubMed |
| Current and Developing Therapeutics for Dry Eye Disease: Targeting Ion Channels. | Curr Issues Mol Biol | 2026 | 41899483 | PubTator, text mining | PubMed |
| Stinging Salvation: Harnessing Scorpion Venom Peptides for Revolutionary Pain Relief. | Toxins (Basel) | 2026 | 41893543 | PubTator, text mining | PubMed |
| Targeted Inactivation of an α/β Hydrolase Gene Enables Discovery of Heterodimeric Nenestatins. | Mar Drugs | 2026 | 41892962 | PubTator, text mining | PubMed |
| Engineered zinc finger repressors induce a prolonged and selective repression of SCN9A in nociceptors of nonhuman primates. | Sci Transl Med | 2026 | 41880518 | PubTator, text mining | PubMed |
| Alternative splicing in voltage-gated sodium channels: mechanisms, regulatory networks and therapeutic implications. | Ann Med | 2026 | 41869747 | PubTator, text mining | PubMed |
| Nav1.8 Variant I206M as a Latent Susceptibility Factor in Postaxotomy Ocular Pain. | Neurol Genet | 2026 | 41868096 | PubTator, text mining | PubMed |
| Expression of Concern: Identification and In-Silico study of non-synonymous functional SNPs in the human SCN9A gene. | PLoS One | 2026 | 41860811 | PubTator, text mining | PubMed |
| Academic Symposium: Empowering the Next Generation to Drive Global Impact in Biomedical Innovation. | BMC Proc | 2026 | 41851716 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6335/papers?page=3